Oral iron absorption test in patients on CAPD: Comparison of ferrous sulfate and a polysaccharide ferric complex?

Nephron

Volumn 74, Issue 2, 1996, Pages 291-294

  Tinawi, Mohammad ^a   Martin, Kevin J ^a   Bastani, Bahar ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Anemia; Continuous ambulatory peritoneal dialysis; Erythropoietin; Iron; Niferex

Indexed keywords

FERROUS SULFATE; IRON; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; TYRAMINE; ERYTHROPOIETIN; FERROUS ION; POLYSACCHARIDE; RECOMBINANT PROTEIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON STORAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; BLOOD; COMPARATIVE STUDY; INTESTINE ABSORPTION; MIDDLE AGED; PROSPECTIVE STUDY; REFERENCE VALUE; TIME;

ADMINISTRATION, ORAL; ADULT; ERYTHROPOIETIN; FEMALE; FERROUS COMPOUNDS; HUMANS; INTESTINAL ABSORPTION; IRON; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; POLYSACCHARIDES; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; REFERENCE VALUES; TIME FACTORS;

EID: 0029658471     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189323     Document Type: Article

References (18)

1. Van Wyck DB, Stivclman JC. Ruiz J. Kirlin LF. Katz MA. Ogden DA: Iron status in patients receiving erythropoietin lor dialysis-associated anemia. Kidney Int 1989:35:712- 716.
2. Levin NM. Lazarus JM, Nissenson AR: National cooperative recombinant human erythropoietin study in patients with chronic renal failure: An interim report. Am J Kidney Dis 1993:22(suppl I):3-12.
3. Van Wyck DB: Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 1989:14:9-13.
4. Domoto DT. Martin KJ: Failure of CAPD patients to respond to an oral iron absorption test. Adv Perit Dial 1992;8:102-104.
5. Kumpf VJ, Holland EG: Parenteral iron dex-tran therapy. DICP 1990:24:162-166.
6. Hamstra RD. Block MH. Schocket AL: Intravenous iron dexlran in clinical medicine. JAMA 1980:243:1726-1731.
7. Bereman RD. Berg KA: The structure, size and solution chemistry of a polysaccharide-iron complex (Niferex). InorgChim Acta 1989:155: 183-189.
8. Berg KA. Bowen LIL Hedges SW. Bereman RD. Vance CT: Identification of ferrihydrile in polvsaccharidc-iron complex by Mossbauer spectroscopy and X-ray diffraction. J Inorg Biochem 1984:22:125-135.
9. Piccinini L. Acotriccot M: Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemia. Panmincrva Med 1982:24:213-220.
10. Johnson CA. Rosowski E. Zimmerman SW: A prospective open-labcl study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving Epogcn. Adv Perit Dial 1991;7:444-447.
11. Wingard RL. Parker RA. Ismail N. Hakim R: Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 1995:25:433-439.
12. Crosby WH. O'Neal-Cutting MA: A small dose iron tolerance test as an indicator of mild iron deficiency. JAMA 1984:251:1986-1987.
13. Josephs HW: Absorption of iron as a problem in human physiology. Blood 1958:13:1-54.
14. Harris CA: Blood Absorption Study of Niferex with a Ferrous Compound Control (unpublished). Seymour, Central Pharmaceuticals, 1971.
15. Conrad ME: Regulation of iron absorption. Prog Clin Biol Res 1993:380:203-219.
16. Hillman RS: Hematopoietic agents: Growth factors, minerals, and vitamins; in Gilman AG. Fall TW. Nics AS. Taylor P (eds): The Pharmacological Basis of Therapeutics. Elmsford. Per-gamon Press 1992. pp 1277-1310.
17. Pru C. Eaton J. Kjcllstrand C: Vitamin C: Intoxication and hvpcroxalemia in chronic hemodialysis patients. Nephron 1985:39:112- 116.
18. Eschbach JW. Cook JD. Scribner BH. Finch CA: Iron balance in hemodialysis patients. Ann Intern Med 1977;87:710-713.